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X-Ray Crystal Structure
of Staphylococcus aureus FemA
peptidoglycan biosynthesis specific to Staphyloccoci
and therefore may serve as suitable targets for the devel-
opment of new antibacterial agents.
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3 Infectious Diseases Biology ramic acid creates the locus upon which a 5-residue
peptide chain is built. Construction of this pentapeptidePharmacia Corporation
301 Henrietta Street is catalyzed in a nonribosomal fashion by the enzymes
MurC [8], MurD [9], MurE [10], and MurF [11] in bothKalamazoo, Michigan 49007
4 Molecular Biology Gram-negative and Gram-positive bacteria. The re-
sulting UDP-N-acetylmuramyl pentapeptide is subse-Human Genome Sciences
9410 West Key Avenue quently attached to an undecaprenyl lipid moiety by
MraY [12] and joined to another sugar, UDP-N-acetylglu-Rockville, Maryland 20850
cosamine, by MurG [13]. In S. aureus, the next stage of
peptidoglycan biosynthesis involves building a penta-
glycine strand on the  amino group of the lysine sideSummary
chain [14]. Similar interpeptide bridges are found in other
Gram-positive organisms including S. carnosus, whichThe latter stages of peptidoglycan biosynthesis in
builds an interpeptide bridge using glycine, S. epider-Staphylococci involve the synthesis of a pentaglycine
midis and S. haemolyticus, which build interpeptidebridge on the  amino group of the pentapeptide lysine
bridges using glycine and serine, S. pneumoniae, whichside chain. Genetic and biochemical evidence suggest
builds interpeptide bridges using serine and alanine, andthat sequential addition of these glycines is catalyzed
E. faecium, which builds interstrand bridges of asparticby three homologous enzymes, FemX (FmhB), FemA,
acid and asparagines [15]. The Gram-positive bacteriaand FemB. The first protein structure from this family,
B. subtilis does not contain an interpeptide bridge, butStaphylococcus aureus FemA, has been solved at 2.1 A˚
like Gram-negative E. coli contains a meso-diaminopi-resolution by X-ray crystallography. The FemA struc-
melic acid in the third position of the pentapeptide thatture reveals a unique organization of several known
is responsible for the crosslinking between strands [16].protein folds involved in peptide and tRNA binding.
The FemXAB family of enzymes is responsible forThe surface of the protein also reveals an L-shaped
the sequential building of this interpeptide strand in S.channel suitable for a peptidoglycan substrate. Analy-
aureus. FemX is responsible for addition of the first gly-sis of the structural features of this enzyme provides
cine to the  amino group of the lysine side chain [17],clues to the mechanism of action of S. aureus FemA.
FemA is responsible for addition of the next 2 glycine
residues, and FemB is responsible for addition of the
Introduction final 2 glycine residues (Figure 1) [18]. Early evidence
suggested that the glycines utilized by the Fem proteins
Over the past few decades, the increasing prevalence of are derived from glycyl-tRNAgly [19, 20]. Recent bio-
antibiotic-resistant bacterial infections has underscored chemical studies on FemX from Lactobacillus virides-
the need to develop new classes of novel antibacterial cens and Enterococcus faecalis have demonstrated in-
agents [1]. Several clinically relevant bacteria, including corporation of alanine into UDP-MurNAc pentapeptide
methicillin-resistant Staphylococcus aureus, have be- from alanyl-tRNAala, suggesting that the utilization of
come the focus of intensive research to identify novel tRNAs as the source of amino acids is a general charac-
targets and inhibitory agents that could be developed teristic of enzymes in the FemXAB family [21, 22].
into suitable antibacterials. The resistance of S. aureus The extended Lys-Gly5 chain in Staphylococci servesto methicillin and other -lactams emerged through the as the interstrand bridge between nearby peptide
acquisition of the gene for another penicillin binding strands during the final stages of crosslinking between
protein, PBP2 (or PBP2a), that can function in the pres- strands in a transpeptidation step catalyzed by penicillin
ence of -lactams. Through a series of genetic studies, binding proteins [23]. Since crosslinking between these
several other genes were identified as factors involved peptide strands is critical for maintaining stability of the
in methicillin resistance. These factors, known as fem bacterial cell wall during changes in osmotic pressure,
(factors essential for methicillin resistance) or aux (auxil- members of the FemXAB family are potential targets for
lary) genes, were shown to be involved directly in cell the development of new antibacterial agents. Genetic
wall biosynthesis or synthesis of associated factors [2]. analysis of these genes has shown that FemX [17] and
Three of these genes, FemX (or FmhB) [3], FemA [4], FemA are essential for the viability of S. aureus, whereas
and FemB [5], play a vital role in the latter stages of
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Figure 1. Biochemical Pathway for Synthesis of the Pentaglycine Bridge by the FemXAB Enzyme Family
FemB does not appear to be essential [24, 25]. The PEG 8000, 0.1 M imidazole [pH 8.0], 0.2 M Ca(OAc)2 and
frozen in liquid nitrogen) provided sufficient data for thelack of essentiality of FemB suggests a shorter glycyl-
peptide bridge of 3 residues (resulting from the action structure determination. S. aureus FemA crystallized as
a monomer in space group P212121 with cell constantsof FemX and FemA) could allow sufficient interstrand
crosslinking to maintain cell viability. The sequence re- a  53.9 A˚, b  90.4 A˚, c  109.3 A˚. The structure of S.
aureus Fem A was solved to 2.1 A˚ by multiple anomalouslatedness of the three fem genes (FemX is 36% homolo-
gous and 23% identical to FemA, FemB is 52% homolo- dispersion (MAD) from the selenomethionine-incorpo-
rated protein crystal (Table 1). The electron density mapgous and 39% identical to FemA) suggests they likely
share the same protein fold (with FemB higher in struc- derived from the MAD phases (Figure 2) showed the
protein main chain and side chains as well as boundtural similarity to FemA than FemX) and that small mole-
cule inhibitors might be found that would inhibit more water molecules with exceptional clarity and permitted
rapid model building and refinement. The only residuesthan one member of the FemXAB family. As part of an
internal structural genomics effort focused on essential not observed in the electron density are the C-terminal
14 amino acids, including the His6 tag (residues 413–protein targets from pathogenic bacteria, the first en-
zyme from the FemXAB family, S. aureus FemA, has 426), and an internal loop of 12 amino acids (residues
209–220). The final model contains 400 residues of thebeen crystallized and its X-ray structure has been solved
to 2.1 A˚ resolution. 426 amino acids present in the protein and 318 water
molecules.
S. aureus FemA folds into a globular domain withResults and Discussion
two helical arms extending into solvent (Figure 3A). The
globular domain (domain 1) has dimensions of 46 A˚ byStructure Determination and Overview
Initial crystals were identified using methionine-incorpo- 58 A˚ by 31 A˚, whereas the helical domain (domain 2) is
48 A˚ by 16 A˚ by 13 A˚. The globular domain of S. aureusrated protein and were subsequently reproduced with
selenomethionine-incorporated protein A single crystal FemA consists of a mixed / structure built upon two
twisted orthogonal  sheets surrounded by 11  helices.of selenomethionine S. aureus Fem A (grown in 10%
Structure of S. aureus FemA
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Table 1. Data Collection and Phasing Statistics
 0.96863 A˚  0.97949 A˚  0.97923 A˚
(12800 eV, remote) (12659.8 eV, edge) (12661.5 eV, peak)
Resolution 2.10 A˚ 2.06 A˚ 2.09 A˚
No. observations 236,796 245,838 244,062
No. unique reflections 32,411 33,970 32,786
Average I/ 22.3 (3.0)1 23.0 (2.6) 25.6 (3.6)
Multiplicity 7.0 (4.6) 6.8 (3.5) 7.3 (4.9)
% completeness 99.7% (97.9%) 98.7% (89.6%) 99.1% (93.2%)
Rsym2 0.060 (0.246) 0.068 (0.245) 0.063 (0.227)
RCullis3 acentrics — 0.90 (0.52/1.00)6 0.90 (0.50/1.00)
RCullis4 anomalous — 0.69 (0.28/0.97) 0.70 (0.25/0.97)
Phasing power5
Centrics — 0.59 (2.13/0.11) 0.55 (2.13/0.13)
Acentrics — 0.59 (2.49/0.17) 0.57 (2.67/0.18)
Mean figure of merit (to 2.1 A˚ resolution)
Before solvent flattening 0.41
After solvent flattening 0.73
1Data for the highest resolution shell are provided in parentheses (for remote  outer shell: 2.17–2.10 A˚; for edge : outer shell 2.13–2.06 A˚;
for peak : outer shell 2.16–2.09 A˚).
2 Rsym  i,(h,k,l)|Ii,(h,k,l) 	 (I(h,k,l))|/i,(h,k,l)(I(h,k,l)), where (I(h,k,l)) is the statistically weighted average intensity of symmetry equivalent reflections keeping
the anomalous pairs separate.
3 RCullis  (h,k.l)||FPH| 	 |FP 
 FH||/(h,k,l)|FPH 	 FP|
4 RCullis anom  (h,k,l)||FPH
 	 FPH	|obsd 	 |FPH
 	 FPH	|calc|/(h,k,l)|FPH
 	 FPH	|obsd
5 Phasing power  |FH|/||FPH| 	 |FP 
 FH||
6 Data in parentheses are for the lowest/highest resolution shells (20–6.8 A˚/2.33–2.10 A˚), respectively.
The Protein Data Bank was searched for folds related with four  helices. Two of the  helices lie on top of
to S. aureus FemA with the program TOP [26] using the the sheet aligned in parallel with the  strands. The other
helical arm domain and the globular domain as separate two  helices are stacked on the bottom of the sheet
search models. Although no single related protein was with one helix aligned in parallel with the  strands and
identified, several protein folds that have appeared in the other at a 60 angle. Superposition of one of the
other structures were found. closest structural matches, the HAT domain of Tetrahy-
mena GCN5, on domain 1A from FemA led to an rms
deviation of 1.5 A˚ for the residues in common (see Exper-Structural Features: Disaccharide Hexapeptide
imental Procedures for further details of the superposi-Lipid Substrate Binding
tions). Superposition of the HAT domain of TetrahymenaAnalysis of the globular domain of FemA revealed two
GCN5 on domain 1B from FemA led to an rms deviationsubdomains (domain 1A, residues 1–110, 129–144, and
of 1.7 A˚ for the residues in common. In addition, domains396–401, and domain 1B, residues 145–166, 189–245,
1A and 1B from S. aureus FemA can be superimposedand 308–395; Figures 3A and 4) that contain secondary
on each other with an rms deviation of 2.4 A˚ for thestructure elements arranged in a three-dimensional fold
atoms in common (Figure 3B). The structure of the glob-similar to the histone acetyltransferase (HAT) domain of
ular domain is completed by five additional elements ofGCN5 and its homologs [27]. Each of these subdomains
contains a central five-stranded mixed polarity  sheet secondary structure that are not part of the HAT-like
Figure 2. A Stereo View of a Section of the
Solvent-Flattened MAD Electron Density Map
The map is contoured at 1  for residues 323–
331 of S. aureus FemA.
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Figure 3. Overview of the Three-Dimensional
Structure of S. aureus FemA
(A) Stereo view of the structure of S. aureus
FemA. The two asterisks mark the location
of the disordered loop between residues 209
and 220. Color coding: domain 1A: yellow
(residues 1–110, 129–144, and 396–401); do-
main 1B: magenta (residues 145–166, 189–
245, and 308–395), green (additional second-
ary structure elements in domain 1: residues
111–128, 167–188, and 402–412); domain 2:
blue (residues 246–307).
(B) Superposition of domains 1A and 1B
(color coding as in [A]).
(C) Stereo view of the backbone of S. aureus
FemA with residues numbered every 20
amino acids.
folds—a pair of  strands (6 and 7) that extend from mena GCN5 or related sequences including the absence
of the consensus sequence observed for Motif A [32].domain 1A, a pair of  helices (5 and 6) that lie on
top of domain 1B, and a C-terminal  helix (13). The other rationale for the presence of the HAT-like
fold would be its ability to bind peptide or peptide-likeStructural studies of the HAT domain of Tetrahymena
GCN5 have shown that this domain is sufficient to bind substrates. The peptide binding region in the Tetrahy-
mena GCN5 HAT domain lies underneath the single two substrates: coenzyme A and a peptide from core
histones that contains a lysine which can be acetylated sheet between the fourth and fifth strands. Identifying
this region within the two FemA subdomains indicates[28]. The presence of a fold that binds coenzyme A
suggested initially there might be a role for coenzyme that the peptide pocket on domain 1A is buried within
the protein (thereby inaccessible for binding of the di-A in the transfer of glycine from the tRNA to the peptide.
Amino-acyl-coenzyme A molecules have been shown saccharide hexapeptide lipid substrate), whereas the
pocket on domain 1B corresponds to a portion of a deepto be involved in nonribosomal peptide synthesis [29,
30] and, in fact, transfer of amino acids from charged L-shaped channel (approximate dimensions: 40 A˚ by
20 A˚) that traverses the surface of S. aureus FemA (Fig-tRNAs to coenzyme A has been demonstrated [31]. Co-
enzyme A could serve as an intermediate between the ure 5). The L-shaped channel that traverses domain 1B
is the only binding cavity on S. aureus FemA suitableglycyl-tRNAgly and the peptidoglycan substrate, but pre-
liminary isothermal denaturation and isothermal titrating for binding the large disaccharide hexapeptide lipid sub-
strate (an extended conformation of the MurNAc:L-Ala-calorimetry studies do not support the binding of coen-
zyme A to S. aureus FemA (data not shown). This result D-Glu-(NH2)-L-Lys(Gly)-D-Ala-D-Ala would measure at
least 30 A˚) . Interestingly, the only break in the mainis consistent with the lack of sequence homology be-
tween S. aureus FemA and the HAT domain of Tetrahy- chain electron density is located over the top of this
Structure of S. aureus FemA
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Figure 4. Sequence Alignment and Secondary Structure
The S. aureus sequences of FemA (construct used in this work including the C-terminal His6 tag; sequence provided by Human Genome
Sciences), FemB (GenBank accession number P14305), and FemX (FmhB; GenBank accession number AAD23961) were aligned using AlignX
in the VectorNTI Suite (InforMax). Identical residues across all three sequences are colored orange and residues conserved in two sequences
are colored aqua. Residue numbers are provided in parentheses at the beginning of each line. Secondary structure elements present in the
S. aureus FemA crystal structure are aligned with the sequence and color coded according to Figure 3A. Key code for secondary structure:
⇒,  sheets; solid bar,  helices; ----, disordered main chain.
channel between helices 7 and 8 (residues 209–220). similar structural feature in the structure of bacterial
seryl-tRNA synthetases [33, 34]. Comparison of theUpon binding of the disaccharide hexapeptide lipid sub-
strate, these 12 residues could close down over the structure of the seryl-tRNA synthetase with and without
tRNA reveals that the structural function of these heliceschannel during the addition of each glycine and then
reopen for release of the product. is to provide a flexible platform to interact with the tRNA
substrate [35, 36]. The presence of the helical arms in
S. aureus FemA suggests that this antiparallel coiled-Structural Features: tRNA Binding
The search of the Protein Data Bank for structures which coil domain could serve to hold an amino acid-charged
tRNA molecule during addition of the glycine residuescontain helical arms such as those observed in domain
2 of FemA (9 and 10: residues 246–307) identified a into the growing pentaglycine bridge, consistent with
Figure 5. Localization of Peptidoglycan Sub-
strate Binding Channel
Domains are colored as in Figure 3. Residues
that line the L-shaped channel are highlighted
on the surface of S. aureus FemA in white.
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Table 2. Refinement Statistics Against  0.96863 A˚ Data
R factor1 Free R factor2 No. of reflections
20–2.1 A˚ F  0  0.183 0.212 31,500
Bonds (A˚) Angles ()
Rms deviation from ideal geometry 0.008 1.35
Number of atoms Average B factor
Protein 3,313 27.3
Domain 1 2,785 25.3
Domain 2 528 37.5
Waters 318 35.0
Total 3,631 27.9
1R factor  (h,k,l)||Fo| 	 Fc||/(h,k,l)|Fo|
2 Free R factor  (h,k,l)T||Fo| 	 |Fc||/(h,k,l)T|Fo|, where T is a test set containing a randomly selected 10% of the observations omitted from the
refinement process.
early studies on the incorporation of glycine in the cell identify structurally related enzymes with known func-
tion, thereby generating hypotheses for the function ofwalls of S. aureus [19, 20, 37, 38]. Significant changes
in the orientation and structure of the coiled-coil domain the protein under study. Subsequent biochemical exper-
iments such as binding studies, biochemical assays,of S. aureus FemA would be expected to occur upon
tRNA binding on the basis of studies of the Thermus and mechanistic studies can be developed to test the
structural hypotheses and ultimately define the bio-thermophilus seryl-tRNA synthetase-tRNA complexes
as well as the mean B factors for S. aureus FemA resi- chemical mechanism.
dues in domain 2 versus domain 1 (Table 2). Such
changes in FemA would enable the enzyme to orient
Experimental Procedures
and position the acceptor end of the tRNA near the
active site for transfer of glycine to the peptidoglycan. Protein Expression and Purification
The sequence of S. aureus FemA was obtained from Human Genome
Sciences. S. aureus FemA was expressed in E. coli using constructBiological Implications
K12S (F lacIq) (pTAC-FemA/4-His6; see Figure 4 for the complete
sequence). Cells from frozen ampules were grown in M9 medium
Current biochemical and genetic evidence supports a containing ampicillin (100 g/ml) and thiamine (10 M) overnight at
37C and reached final densities of 4 A550. When the cell densityrole for S. aureus FemA in addition of two glycines to
reached 0.8 A550 methionine biosynthesis was downregulated bythe amino terminus of Lys-Gly within the S. aureus pepti-
the addition of an amino acid cocktail (L-lysine, L-threonine,doglycan. The binding site for the disaccharide hexa-
L-phenylalanine, and DL-selenomethionine at final concentrationspeptide lipid substrate is proposed to be the L-shaped
of 100 g/ml and L-leucine, L-isoleucine, and L-valine at final con-
channel found on one face of the globular domain as centrations of 50 g/ml) [39]. Selenomethionine (SeMet)-FemA ex-
shown in Figure 5. The second macromolecule, glycyl- pression was induced by the addition of IPTG (1 mM final concentra-
tion) 15 min after addition of the amino acids, when the cell densitytRNAgly, can be readily accommodated at the junction
was 1 A550. At 3 hr postinduction, the cells were harvested bybetween the helical arms and the globular domain of
centrifugation and frozen for later use.FemA, with the coiled-coil domain serving to anchor the
A 70.9 g pellet of SeMet-FemA was thawed at room temperaturetRNA in position for catalytic transfer.
for 10–15 min prior to resuspending in lysis buffer (50 mM Tris-
Structural folds often give clues for the function and HCl [pH 8.5], 5 mM -mercaptoethanol, 1.8 g/L lysozyme, 100 mg/L
mechanism of novel proteins that might not be deter- DNase, Complete protease inhibitor tablets [Boehringer Mannheim;
1 per 50 ml]) at 6–7 ml of buffer per gram of cell paste. The cellmined by sequence comparison. Analysis of the struc-
suspension was kept on ice for 1.5 hr with intermittent mechanicalture of S. aureus FemA and comparison between its
disruption via use of a tissuemizer. At the end of lysis, the solublestructure and related structures in the Protein Data Bank
product was separated from insoluble cellular debris by addition ofprovide the evidence that S. aureus FemA is able to
tergitol 15-S-7 to 4%. The sample was stirred for 30 min at 4C
bind both glycyl-tRNAgly and the disaccharide hexapep- and was then clarified by centrifugation at 17,000  g at 4C for
tide lipid substrate. The current structural data suggest 30 min. NaCl was added to 0.5 M and imidazole to 25 mM to the
clarified lysates.direct transfer of the glycine from the glycyl-tRNAgly to
Clarified cell lysates were loaded onto a column (1 ml per g ofthe peptidoglycan. Attack of the free amino group from
cell paste; 2.5 cm id) of Ni
2-NTA agarose (Qiagen) which had beenthe Gly-Lys-pentapeptide on the glycyl-tRNAgly would
prewashed with water and equilibrated with buffer (50 mM Tris-HCl,extend the glycine chain by 1 residue. A subsequent
0.5 M NaCl [pH 8.5], 5 mM -mercaptoethanol, 25 mM imidazole).
round of glycyl-tRNAgly binding and transfer would ac- The lysate was loaded onto the column, and then the column was
count for the addition of the second glycine. While the washed with additional buffer until the absorbance returned to base-
line. The column was eluted by washing successively with bufferaddition of two glycines by FemA is proposed to occur
containing 50 mM imidazole, and then with buffer containing eitherin a sequential fashion, details of a specific mechanism
250 mM imidazole or with buffer containing 100 mM imidazole fol-must await detailed biochemical studies of the enzyme
lowed by 300 mM imidazole. During the last washes, the eluateand further structural studies with bound substrates.
was collected in 1–2 min fractions (2.5–5.0 ml). Throughout the
This study demonstrates the value of obtaining X-ray chromatography the flow rate was 2.5 ml/min, and the absorbance
crystal structures of unknown or undercharacterized was monitored at 276–278 nm. Fractions were assayed for purity
of FemA by SDS-PAGE.proteins. Access to structural information allows one to
Structure of S. aureus FemA
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IMAC-purified FemA was diluted 1:10 with 50 mM ethanolamine 401 from S. aureus FemA and residues A49–A54, A63–A69, A94–
A101, A105–A116, A120–A124, A136–A160, and A198–A202 from(pH 10.0), 1 mM dithiothreitol after which it was loaded onto a 20 ml
column (2.5 cm id) of Source 30Q (Amersham-Pharmacia Biotech) Tetrahymena GCN5, giving an rms deviation of 1.5 A˚. Superposition
of Tetrahymena GCN5 on FemA domain 1B included residues 191–anion exchange chromatography medium which had been equili-
brated in the same buffer. Following loading, each column was 197, 200–208, 236–243, 311–321, 324–337, 339–362, 378–386, and
157–163 from S. aureus FemA and residues A49–A55, A65–A73,washed with additional buffer until the absorbance reached base-
line. The columns were then eluted via a linear gradient from 0 to A94–A101, A105–A115, A120–A133, A164–A172, A196–A202 from
Tetrahymena GCN5, giving an rms deviation of 1.7 A˚. Residues from250 mM NaCl over ten column volumes. Again, the column was
washed and eluted at 2.5 ml/min. The eluate was monitored at 278 subdomain 1A (residues 1–17, 28–34, 40–47, 52–62, 69–78, 85–107,
and 398–401) from one molecule of S. aureus FemA were superim-nm. Fractions were assayed for purity of FemA by SDS-PAGE.
posed on the corresponding residues from subdomain 1B (residues
191–208, 223–229, 236–243, 312–322, 324–333, 341–363, and 160–Crystallization
162), giving an rms deviation of 2.4 A˚. Figures prepared using Mol-S. aureus
script [52] include Figures 3A and 3C. Raster3d was also used inFem A was dialyzed into 50 mM ethanolamine, 1 mM DTT (pH 10.0).
the preparation of Figure 3A [53].The protein was concentrated in an Ultrafree-4 30,000 molecular
weight cut-off filtration unit (Millipore) to 12 mg/ml. Initial crystals
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